FAKTOR OPTIONSSCHEIN - AMBU Stock

Certificat

DE000PE6AMB6

Market Closed - Deutsche Boerse AG 10:21:12 2024-07-05 am EDT
12.17 EUR +1.93% Intraday chart for FAKTOR OPTIONSSCHEIN - AMBU
Current month+16.02%
1 month+17.36%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-05 12.17 +1.93%
24-07-04 11.94 -2.21%
24-07-03 12.21 +3.65%
24-07-02 11.78 -0.42%
24-07-01 11.83 +12.77%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 10:21 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying AMBU A/S
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE6AMB
ISINDE000PE6AMB6
Date issued 2023-03-09
Strike 138 kr
Maturity Unlimited
Parity 1 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 89.72
Lowest since issue 0.7
Spread 1.14
Spread %8.42%

Company Profile

Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (56.3%); - emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).
Sector
-
More about the company

Ratings for Ambu A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Ambu A/S

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
138 DKK
Average target price
117 DKK
Spread / Average Target
-15.22%
Consensus